Nicox SA Performance

NICXFDelisted Stock  USD 0.44  0.00  0.00%   
The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Nicox SA are completely uncorrelated.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nicox SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Nicox SA is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Begin Period Cash Flow47.2 M
Total Cashflows From Investing Activities-175 K
  

Nicox SA Relative Risk vs. Return Landscape

If you would invest (100.00) in Nicox SA on August 30, 2024 and sell it today you would earn a total of  100.00  from holding Nicox SA or generate -100.0% return on investment over 90 days. Nicox SA is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than Nicox, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  

Nicox SA Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nicox SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Nicox SA, and traders can use it to determine the average amount a Nicox SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NICXF
Based on monthly moving average Nicox SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nicox SA by adding Nicox SA to a well-diversified portfolio.

Nicox SA Fundamentals Growth

Nicox Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Nicox SA, and Nicox SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Nicox Pink Sheet performance.

About Nicox SA Performance

By analyzing Nicox SA's fundamental ratios, stakeholders can gain valuable insights into Nicox SA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Nicox SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Nicox SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Nicox S.A. operates as an ophthalmology company in France and internationally. The company was founded in 1996 and is headquartered in Valbonne, France. Nicox Sa operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 32 people.

Things to note about Nicox SA performance evaluation

Checking the ongoing alerts about Nicox SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Nicox SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Nicox SA is not yet fully synchronised with the market data
Nicox SA has some characteristics of a very speculative penny stock
Nicox SA has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 8.58 M. Net Loss for the year was (43.76 M) with profit before overhead, payroll, taxes, and interest of 7.23 M.
Nicox SA has accumulated about 41.97 M in cash with (18.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.98, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Nicox SA's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Nicox SA's pink sheet performance include:
  • Analyzing Nicox SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Nicox SA's stock is overvalued or undervalued compared to its peers.
  • Examining Nicox SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Nicox SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Nicox SA's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Nicox SA's pink sheet. These opinions can provide insight into Nicox SA's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Nicox SA's pink sheet performance is not an exact science, and many factors can impact Nicox SA's pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Nicox Pink Sheet

If you are still planning to invest in Nicox SA check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nicox SA's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Money Managers
Screen money managers from public funds and ETFs managed around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum